EPRX (eupraxiapharma.com) Market Value

Official company branding of Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals (EPRX) protects its business through patents and strict FDA standards, while the high cost of sterile manufacturing creates a robust market moat. The company develops drug delivery systems to combat inflammation, targeting the orthopedic B2B segment via innovative microspheres. Current market capitalization stands at 0.55. The asset's market value dynamics on GURU.Markets are supplemented by data on partnerships with medical centers for testing extended-release drugs.

EPRX (Eupraxia Pharmaceuticals, Inc.) Market Capitalization history from 04/06/2024 to 11/16/2026

Comprehensive metric breakdowns and analytics for Eupraxia Pharmaceuticals Inc. (EPRX)

Fundamental company analysis:EPRX (Eupraxia Pharmaceuticals Inc.)
Product sample of eupraxiapharma.com

As a manager, I evaluate this asset through the lens of market confidence. This metric is calculated as the product of the current share price and the total number of outstanding shares, measuring the aggregate value of the business. By analyzing the history of the company's market capitalization, an investor can observe the dynamics of how the market values the assets. For Eupraxia Pharmaceuticals (EPRX), this metric reflects the speculative value of future developments. High R&D expenditures coupled with a revenue deficit make the capitalization extremely sensitive to any news regarding financing.

Key competitors

Market Value Haleon Group HLN|Kenvue Inc. - Market Value|VRNA - Market Value|MENS (jyongbio.com) - Market Capitalization|LGND: Market Capitalization|Market Capitalization AMRX|Market Value Perrigo|Alvotech Corp - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos NV) - Market Value|Market Capitalization ANIP (anipharmaceuticals.com)|Market Capitalization MannKind Corp MNKD|AMPH - Market Value|Market Value PCRX (Pacira Corp)|ars-pharma.com (SPRY) - Market Value|Market Valuation Theravance Biopharma|AQST (aquestive.com) - Market Capitalization|Market Capitalization scPharmaceuticals|Market Valuation TECX (Tectonic Therapeutic Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Market Value|Market Value China SXT Pharmaceuticals, Inc. SXTC|BioHarvest Sciences Inc. (BHST) - Market Value|EXOZ: Market Valuation|oramed.com - Market Value|ENTX: Market Capitalization|MindWalk - Market Value|ABVC (ABVC BioPharma Inc.) - Market Capitalization|Market Value cumberlandpharma.com CPIX|Market Value Quantum BioPharma (QNTM)|FGEN (FibroGen) - Market Value|Telomir Pharmaceuticals, Inc. - Market Valuation|Market Value RANI|SNYR: Market Valuation|RLYB - Market Capitalization|LEXX (Lexaria Bioscience) - Market Valuation|PULM (Pulmatrix Inc) - Market Value|Market Valuation PTHL|APM: Market Value|Market Valuation LYRA (Lyra Therapeutics, Inc.)|Market Value IBO|Market Capitalization TNFA (TNF Pharmaceuticals)|Market Value YCBD|PainReform - Market Capitalization|Market Value CYTO (altamiratherapeutics.com)|LIPO (Lipella Pharmaceuticals) - Market Valuation|Market Value OptiNose (OPTN)|PIRS (Pieris Pharmaceuticals, Inc.) - Market Capitalization|PROC - Market Capitalization|Market Capitalization PTPI|QLI - Market Value|Market Value ACELYRIN SLRN|TFFP - Market Valuation